OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 87 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $999,069 | -18.4% | 88,257 | +1.2% | 0.00% | -100.0% |
| Q4 2023 | $1,224,146 | -53.7% | 87,252 | -59.2% | 0.00% | 0.0% |
| Q3 2023 | $2,644,061 | +9.4% | 214,094 | -20.0% | 0.00% | 0.0% |
| Q2 2023 | $2,416,040 | +925585.8% | 267,557 | +255.7% | 0.00% | – |
| Q1 2023 | $261 | -85.5% | 75,224 | -89.8% | 0.00% | -100.0% |
| Q4 2022 | $1,803 | -99.9% | 735,953 | +8.5% | 0.00% | 0.0% |
| Q3 2022 | $1,873,000 | -28.5% | 678,598 | +5.5% | 0.00% | -50.0% |
| Q2 2022 | $2,618,000 | +619.2% | 643,344 | +653.2% | 0.00% | – |
| Q1 2022 | $364,000 | -84.3% | 85,417 | -65.6% | 0.00% | -100.0% |
| Q4 2021 | $2,324,000 | +742.0% | 248,328 | +2383.3% | 0.00% | – |
| Q3 2021 | $276,000 | -69.1% | 10,000 | -46.1% | 0.00% | -100.0% |
| Q4 2020 | $892,000 | – | 18,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 4,383,875 | $49,625,465 | 4.02% |
| MPM BioImpact LLC | 1,953,690 | $22,115,771 | 3.56% |
| Ally Bridge Group (NY) LLC | 559,035 | $6,328,276 | 3.52% |
| Paradigm Biocapital Advisors LP | 7,903,600 | $89,468,752 | 3.15% |
| BVF INC/IL | 9,135,893 | $103,418,309 | 2.84% |
| Altium Capital Management LP | 605,000 | $6,848,600 | 2.71% |
| Vivo Capital, LLC | 1,873,704 | $21,210,329 | 1.67% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 515,317 | $5,833,388 | 1.62% |
| Exome Asset Management LLC | 143,400 | $1,623,288 | 1.39% |
| Deep Track Capital, LP | 3,225,419 | $36,511,743 | 1.05% |